Member Info for gixer

sphinx100, The patent has been out there for a while now I was just pointing out that it had now been published in Japan.
The translation from Japanese seems a little misleading.

ABSTRACT
(EN) Provided herein is technology relating to tomato extracts and particularly, but not exclusively to preparing and using tomato extracts as an anti-hypertensive agent to modulate blood pressure.

https://patentscope.wipo.int/search/en/detail.jsf?docId=EP131292726&tab=NATIONALBIBLIO&office=&prevFilter=&sortOption=Relevance&queryString=ALLTXT%3A%28fruitflow%29&recNum=21&maxRec=37

Yip, Been known about for a while.

https://www.sponser.ch/ch_de/nitroflow-performance-blackcurrant-10-x-7g.html

Fruitflow + NO3 to reduce the effects of acute exercise maybe one of the new concepts.

Brazil.

https://www.terra.com.br/noticias/dino/2-edicao-do-wellfood-ingredients-traz-as-mais-recentes-solucoes-para-a-industria-de-alimentos-e-bebidas-funcionais-e-saudaveis,0f92393b06c1fe978c5926ef5b461dc4qdyb90tk.html

A global science-based company, purpose-led and active in Nutrition, Health and Sustainable Living, the Dutch DSM will share its know-how in participating in the Congress with the lecture "Understanding the future of Nutrition and Fortification: a dive into the macro and micro trends that will impact the market, "which will be led by Ana Maria Carvajal, leader of the DSM Food & Beverages segment for Latin America. On the shelf, DSM will have samples from FloraGLO®) and OPTISHARP®), lutein and zeaxanthin-carotenoid brands that promote eye health focused on children and explore the blue light theme. In addition, DSM will have Fruitflow®, a product developed from the bioactive film compounds that cover the seeds of mature tomatoes and reduces the toxic effects of the exercises and was used by the Sunweb team,

https://www.wellfoodsummit.com.br/lista-expositor/?busca=dsm&inicial1=&inicial2=&sort=

DSM promotes a healthy and new life by promoting diversified precision nutrition solutions
http://www.sh.chinanews.com/yljk/2019-03-26/53994.shtml

Global Dietary Supplement Market Future Growth report mentions Provexis launch of FruitFlow+Omega-3
https://www.medgadget.com/2019/03/global-dietary-supplement-market-future-growth-opportunities-and-challenges-in-2019-2026-major-players-are-ekso-bionics-intuitive-surgical-medtronic-stryker-smith-nephew-and-other.html

Fruitflow® – DSM presents new concepts for Fruitflow® at Vitafoods Europe 2019
https://www.provexis.org/?news=fruitflow-dsm-presents-new-concepts-for-fruitflow-at-vitafoods-europe-2019

Be interesting to find out what these new concepts are.

This is an old document but page 20 shows a concept that dsm was working on.
https://www.provexis.org/wp-content/uploads/DSM-presentation-Fruitflow-Food-Matters-Live-London-19-Nov-14.pdf

"The Alliance is seeing the partners collaborate to develop
Fruitflow® in all major global markets, through an effective commercialisation of current formats and pioneering
new and significant applications"

https://provexis.org/wp-content/uploads/2018/09/Provexis-plc-annual-report-31-Mar-18-FINAL-TYPESIGNED.pdf

I don't think Fruitflow as is can be referred to as a new concept.

"This includes new concepts (for men’s health, for instance) featuring the innovative, tomato-based Fruitflow® ingredient, which is part of DSM’s proprietary nutraceutical ingredient range."

https://www.dsm.com/corporate/media/informationcenter-news/2019/03/2019-03-20-dsm-presents-consumer-driven-customized-innovation-at-vitafoods-europe-2019.html

Any thoughts on what the "new concept" for Fruitflow might be?

https://uschinahpa.org/2019/03/by-health-released-2018-annual-report/

MAY 18 MegsMenopause Conference 2019
https://www.eventbrite.co.uk/e/megsmenopause-conference-2019-tickets-53195181219

DSM presents consumer-driven customized innovation at Vitafoods Europe 2019
https://www.marketscreener.com/ROYAL-DSM-6279/news/Royal-DSM-DSM-presents-consumer-driven-customized-innovation-at-Vitafoods-Europe-2019-28198314/

China
What are the solutions for the health of the elderly in the era of accelerated aging?
https://news.21food.cn/29/2838519.html

Freestream
https://vimeo.com/317243303

Don't know but you could try asking flyfit. https://www.flyfit.com/contact/

http://www.pax-intl.com/product-news-events%2Ffood-and-beverage%2F2019%2F03%2F19%2Fintroducing-flyfit-flow-hydration-tablets%2F#.XJHNuij7TIU

There was never any information given to say they had pulled out.

With an old name

https://www.youtube.com/watch?v=ZhWwhUt_NyM

alfista, this is just an observation but it looks like Mr L purchased 40,919,444 shares on or around 7-3-19 shown as a sell. Add the 13 million on 12-3-19 and this adds up to 53,919,444
On the 4-8-2017 Rising Stars were reported as holding 55,919,444

IMO The 2 large sells shown were RS sells.
Did Mr L buy them all??? Who knows but it looks like RS could be out.

No sign of the App yet.

another

https://www.youtube.com/watch?v=3Ih0wsIcTEE

https://www.youtube.com/watch?v=hhPBlnnCr2M

Not if you read the interim report of December 2018.

They both do.

The establishment of the Alliance Agreement was a significant milestone in the history of the Company. The Alliance is seeing the partners collaborate to develop Fruitflow® in all major global markets, through an effective commercialisation of current formats and pioneering new and significant applications. DSM is responsible for manufacturing, marketing and selling via its substantial sales force. Provexis is responsible for contributing scientific expertise necessary for successful commercialisation, and for maintaining and strengthening the breadth and duration of its patent and trade mark coverage for Fruitflow®, seeking to maximise the commercial returns that can be achieved from the technology.

"Profits from the Alliance are being shared by the parties on an agreed basis, linked to various performance milestones. In June 2015 the Company confirmed that it had agreed significantly enhanced financial terms with DSM for the Company's Alliance Agreement for Fruitflow®."

https://otp.investis.com/clients/uk/provexis_plc/rns/regulatory-story.aspx?cid=1569&newsid=1192993